pemetrexed baxter
baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - Антинеопластични средства - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.
uromitexan 100 mg/ml solution for injection
baxter oncology gmbh. - Месны - 100 mg/ml solution for injection
endoxan 200 mg powder for solution for injection
baxter oncology gmbh. - Циклофосфамид - 200 mg powder for solution for injection
endoxan 500 mg powder for solution for injection
baxter oncology gmbh. - Циклофосфамид - 500 mg powder for solution for injection
endoxan 1 g powder for solution for injection
baxter oncology gmbh. - Циклофосфамид - 1 g powder for solution for injection
holoxan 500 mg powder for solution for infusion
baxter oncology gmbh. - Ифосфамид - 500 mg powder for solution for infusion
holoxan 1 g powder for solution for infusion
baxter oncology gmbh. - Ифосфамид - 1 g powder for solution for infusion
holoxan 2 g powder for solution for infusion
baxter oncology gmbh. - Ифосфамид - 2 g powder for solution for infusion
endoxan 50 mg coated tablets
baxter oncology gmbh. - Циклофосфамид - 50 mg coated tablets
oncotrone 2 mg/ml solution for injection/infusion
baxter oncology gmbh. - Митоксантрон - 2 mg/ml solution for injection/infusion